Company Comparison
Evelo Biosciences vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Evelo Biosciences | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Lagos, Nigeria |
| Founded | 2014 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $260M | $45M |
| Valuation | — | — |
What They Build
Evelo Biosciences
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Evelo Biosciences
Sector Overlap
Both Evelo Biosciences and 54gene operate in Biotech.
Browse all Biotech companies →